Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study

@inproceedings{Shizuta2011PrognosticUO,
  title={Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study},
  author={Satoshi Shizuta and Kenji Ando and Masakiyo Nobuyoshi and Takanori Ikeda and Hideaki Yoshino and Shinichi Hiramatsu and Yukio Kazatani and Kohei Yamashiro and Katsunori Okajima and Teishi Kajiya and Yoshinori Kobayashi and Takao Kato and Satoki Fujii and Kazuaki Mitsudo and Koichi Inoue and Hiroshi Ito and Yoshisumi Haruna and Takahiro Doi and Yukiko Nishio and Neiko Ozasa and Kei Nishiyama and Toru Kita and Takeshi Morimoto and Takeshi Kimura},
  booktitle={Clinical Research in Cardiology},
  year={2011}
}
The predictive value of T-wave alternans (TWA) for lethal ventricular tachyarrhythmia in patients with left ventricular (LV) dysfunction is controversial. Also, long-term arrhythmia risk of patients ineligible for the TWA test is unknown. This was a multicenter, prospective observational study of patients with LV ejection fraction ≤40% due to ischemic or non-ischemic cardiomyopathies, designed to evaluate the prognostic value of TWA for lethal ventricular tachyarrhythmia. The primary end point… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS